Hiroyuki Tsunoda Selected Research

Thrombocytopenia (Thrombopenia)

1/2005

A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Tsunoda Research Topics

Disease

5	Neoplasms (Cancer) 01/2024 - 12/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2023
2	Hepatocellular Carcinoma (Hepatoma) 11/2010 - 04/2004
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023
1	Multiple Myeloma 01/2019
1	Atypical Hemolytic Uremic Syndrome 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2017
1	Eosinophilia 09/2013
1	Kimura Disease 09/2013
1	Hemophilia A (Haemophilia) 10/2012
1	Hemorrhage 10/2012
1	Liver Neoplasms (Liver Cancer) 12/2008
1	Melanoma (Melanoma, Malignant) 05/2007
1	Microsatellite Instability 12/2005
1	Colorectal Neoplasms (Colorectal Cancer) 12/2005
1	Thrombocytopenia (Thrombopenia) 01/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2004

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 10/2023 - 05/2007
3	GlypicansIBA 11/2010 - 04/2004
2	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2023
2	codrituzumabIBA 11/2010 - 12/2008
1	C-Reactive ProteinIBA 01/2024
1	Albumin-Bound Paclitaxel FDA Link 10/2023
1	Gemcitabine FDA Link 10/2023
1	Levofloxacin (Levaquin)FDA Link 10/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2023
1	tocilizumab (atlizumab)FDA Link 10/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2023
1	Interleukin-6 (Interleukin 6)IBA 10/2023
1	130-nm albumin-bound paclitaxelIBA 10/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	AntibodiesIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	AntigensIBA 01/2019
1	eculizumab FDA Link 01/2017
1	Complement C5 (Complement 5)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 09/2013
1	CytokinesIBA 09/2013
1	Factor VIII (Coagulation Factor VIII)IBA 10/2012
1	Hemostatics (Antihemorrhagics)IBA 10/2012
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 11/2010
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2010
1	CarbohydratesIBA 12/2008
1	Antineoplastic Agents (Antineoplastics)IBA 12/2008
1	G(M3) GangliosideIBA 05/2007
1	Immunoglobulin M (IgM)IBA 05/2007
1	Complement System Proteins (Complement)IBA 05/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2005
1	Thrombopoietin ReceptorsIBA 01/2005
1	Biomarkers (Surrogate Marker)IBA 04/2004
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2004

Therapy/Procedure

2	Therapeutics 03/2024 - 01/2019
1	Immunotherapy 01/2023
1	Injections 10/2012